Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Sustanon 250
Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, Testosterone Decanoate
- Compound
- Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, Testosterone Decanoate
- Category
- Injectable Steroids
- Brand
- Sustanon
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 10 ml
- Strength
- 250 mg/ml
- Route
- Injection
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for Sustanon 250 are not yet published. They will be added here once testing is complete.
Product information
About Sustanon 250
250 mg/mL · 10 mL · Zyvex Pharmaceuticals
Sustanon 250 from Zyvex Pharmaceuticals is a mixed testosterone ester preparation with a combined strength of 250 mg/mL in a 10 mL pack. Sustanon combines four testosterone esters with different release characteristics.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Basic Identification & Composition
Product Name & Active Ingredient
Sustanon 250 is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is Sustanon, classified as a mixed testosterone ester preparation.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Product name | Sustanon 250 |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredients | Testosterone propionate; testosterone phenylpropionate; testosterone isocaproate; testosterone decanoate |
| Combined strength | 250 mg/mL of the ester mixture |
| Package | 10 mL |
| Drug class | Mixed testosterone ester preparation |
| Chemical formula | Mixture of four testosterone esters; no single molecular formula |
| Common blend name | Sustanon |
| Presentation | Injectable preparation; route as verified on the medicinal label |
Dosage Form
An injectable preparation supplied by concentration and pack volume. The vehicle and whether the preparation is a solution or suspension affect handling. Administration must follow the exact medicinal label and appropriate sterile technique; do not infer the route from concentration alone.
Clinical Particulars
Sustanon 250 uses
Sustanon 250 from Zyvex Pharmaceuticals is a Sustanon testosterone-ester blend. Sustanon is a blend of testosterone esters used for testosterone replacement in confirmed hypogonadism. The different esters provide a mixture of release rates; they are not separate treatments to be dosed independently.
People also use Sustanon for muscle and strength gains or perceived libido and energy benefits. These aims differ from correcting a measured deficiency and do not establish a general wellbeing benefit.
A medicinal reference describes 1 mL of a 250 mg/mL preparation about every three weeks, adjusted to the individual. This is a replacement-treatment example, not a bodybuilding schedule or verification of equivalence of this manufacturer's preparation. Testosterone and haematocrit monitoring remain important.
Dosage and Administration
Sustanon requires a clinician-selected intramuscular dose and interval, followed by clinical and testosterone-level monitoring. The 250 mg/mL concentration describes the combined ester content, not 250 mg of unesterified testosterone. A trained professional should confirm the formulation and administered volume. The dose, treatment interval and duration must be set by the treating clinician. Strength describes the amount of active ingredient in a tablet or millilitre; it does not by itself define a safe dose. Do not increase the dose, combine products or extend treatment without review.
Contraindications
Do not use during pregnancy or with known or suspected prostate or male breast cancer. Allergy to testosterone or an excipient is a contraindication. Serious cardiac, hepatic or renal disease and high haematocrit require assessment before treatment.
Warnings and Precautions
Testosterone can increase haematocrit and blood pressure, suppress sperm production and cause fluid retention. Review testosterone concentrations, blood count and prostate health as appropriate. Assess sleep apnoea and clotting risk. New breathlessness, chest pain or unilateral leg swelling needs urgent evaluation. Check the exact formulation for excipient allergies before injection.
Risks and Interactions
Drug & Food Interactions
Androgens may alter the response to anticoagulants and glucose-lowering medicines. Corticosteroids can add to fluid retention. Review other hormones, supplements and alcohol use with the treating clinician rather than combining them to manage unwanted effects.
Pregnancy and Lactation
Avoid during pregnancy because androgen exposure can affect fetal sexual development. Breastfeeding requires specialist advice. Suppression of gonadotropins can reduce sperm production and fertility; recovery is variable.
Side Effects and Adverse Reactions
Possible class effects include acne, hair changes, altered libido, fluid retention, mood changes, menstrual disturbance and suppression of testicular function. Adverse cholesterol changes and increased haematocrit may be clinically significant. Frequencies cannot be assumed to be the same for all androgens. Injection-site reactions can also occur.
Overdose Protocol
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Scientific & Technical Data
Pharmacodynamics
Sustanon combines testosterone esters with different release characteristics. After cleavage, they release testosterone, which acts at androgen receptors and can be converted to dihydrotestosterone and oestradiol.
Pharmacokinetics
The mixture produces a changing testosterone concentration over time rather than one simple blend half-life. Reference medicinal data show a rise after injection followed by a gradual decline. Ester proportions, vehicle and dose affect that profile, so clinical monitoring remains necessary.
Storage and Handling
Sustanon medicinal injections are commonly stored below 30°C in their original packaging, protected from light, and should not be refrigerated or frozen. Follow the exact pack's validated conditions. The discard rules for a single-use ampoule must not be assumed to apply to a 10 mL vial. Keep injectable medicines in their original packaging, protected from light and excessive heat and out of children's reach. Follow the finished medicine's temperature limits and expiry date. Check the container and solution before use. A vial's size does not establish whether it can be reused: follow its single-dose or multidose instructions and the specified discard time after opening. Dispose of needles in a sharps container.
Browse more